Cambridge Investment Research Advisors’s Keel Infrastructure Corp KEEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.27M Buy
221,146
+7,038
+3% +$30.2K ﹤0.01% 2080
2026
Q1
$418K Buy
214,108
+3,275
+2% +$7.69K ﹤0.01% 2972
2025
Q4
$495K Buy
210,833
+9,434
+5% +$32.3K ﹤0.01% 2728
2025
Q3
$568K Buy
201,399
+25,952
+15% +$40.3K ﹤0.01% 2553
2025
Q2
$147K Hold
175,447
﹤0.01% 3416
2025
Q1
$138K Sell
175,447
-228
-0.1% -$302 ﹤0.01% 3295
2024
Q4
$262K Sell
175,675
-2,592
-1% -$5.18K ﹤0.01% 2951
2024
Q3
$376K Sell
178,267
-1,000
-0.6% -$2.32K ﹤0.01% 2650
2024
Q2
$461K Buy
179,267
+890
+0.5% +$1.92K ﹤0.01% 2366
2024
Q1
$398K Buy
178,377
+2,930
+2% +$7.62K ﹤0.01% 2473
2023
Q4
$511K Buy
175,447
+12
+0% +$19 ﹤0.01% 2161
2023
Q3
$188K Buy
+175,435
New +$256K ﹤0.01% 2833

Other funds holding KEEL

Cambridge Investment Research Advisors's KEEL Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Keel Infrastructure Corp (KEEL) stake by 3.3% in Q2 2026, buying an estimated $30.2K and bringing the position to 221,146 shares worth $1.27M. The position accounts for ﹤0.01% of the portfolio, ranked #2080.

Cambridge Investment Research Advisors first reported a position in KEEL in Q3 2023 and has held it in 12 quarters since. 280 funds tracked by Wall St. Rank hold KEEL as of Q2 2026.

  • Cambridge Investment Research Advisors held 221,146 shares of Keel Infrastructure Corp worth $1.27M as of Q2 2026.
  • Cambridge Investment Research Advisors bought 7,038 Keel Infrastructure Corp shares in Q2 2026, an estimated $30.2K.
  • Keel Infrastructure Corp made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2080 holding.
  • Cambridge Investment Research Advisors first reported a position in Keel Infrastructure Corp in Q3 2023 and has held it in 12 quarters since.
  • 280 funds tracked by Wall St. Rank held Keel Infrastructure Corp as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.